{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T06:32:32Z","timestamp":1723185152382},"reference-count":23,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.23049","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T22:15:53Z","timestamp":1711577753000},"page":"52-58","source":"Crossref","is-referenced-by-count":1,"title":["Extranodal natural killer\/T-cell lymphoma coexisting with peripheral T-cell lymphoma, not otherwise specified"],"prefix":"10.3960","volume":"64","author":[{"given":"Kenta","family":"Hayashino","sequence":"first","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"},{"name":"Department of Hematology and Oncology, Okayama University Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chikamasa","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ayata","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryouya","family":"Yukawa","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aya","family":"Komura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Meguri","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakako","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Pathology, Okayama City Hospital, Okayama-shi, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Imajo","sequence":"additional","affiliation":[{"name":"Department of Hematology, Okayama City Hospital, Okayama-shi, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Au WY, Weisenburger DD, Intragumtornchai T <i>et al.<\/i> Clinical differences between nasal and extranasal natural killer\/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project. Blood. 2009; 113: 3931-3937.","DOI":"10.1182\/blood-2008-10-185256"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Yamaguchi M, Suzuki R, Oguchi M. Advances in the treatment of extranodal NK\/T-cell lymphoma, nasal type [internet]. Blood. 2018; 131: 2528-2540.","DOI":"10.1182\/blood-2017-12-791418"},{"key":"3","unstructured":"3 Haverkos BM, Coleman C, Gru AA <i>et al.<\/i> Emerging insights on the pathogenesis and treatment of extranodal NK\/T cell lymphomas (ENKTL). Discov Med. 2017; 23: 189-199."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 de Mel S, Hue SSS, Jeyasekharan AD, Chng WJ, Ng SB. Molecular pathogenic pathways in extranodal NK\/T cell lymphoma. J Hematol Oncol. 2019; 12: 33.","DOI":"10.1186\/s13045-019-0716-7"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Haverkos BM, Pan Z, Gru AA <i>et al.<\/i> Extranodal NK\/T cell lymphoma, nasal type (ENKTL-NT): an update on epidemiology, clinical presentation, and natural history in North American and European cases [internet]. Curr Hematol Malig Rep. 2016; 11: 514-527.","DOI":"10.1007\/s11899-016-0355-9"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Suzuki R, Suzumiya J, Yamaguchi M <i>et al.<\/i> Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type. Ann Oncol. 2010; 21: 1032-1040.","DOI":"10.1093\/annonc\/mdp418"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Montes-Mojarro IA, Kim WY, Fend F, Quintanilla-Martinez L. Epstein - Barr virus positive T and NK-cell lymphoproliferations: morphological features and differential diagnosis. Semin Diagn Pathol. 2020; 37: 32-46.","DOI":"10.1053\/j.semdp.2019.12.004"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 S\u00e1nchez-Romero C, Bologna-Molina R, Paes de Almeida O <i>et al.<\/i> Extranodal NK\/T cell lymphoma, nasal type: an updated overview. Crit Rev Oncol Hematol. 2021; 159: 103237.","DOI":"10.1016\/j.critrevonc.2021.103237"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol. 2008; 26: 4124-4130.","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood. 2017; 129: 1103-1112.","DOI":"10.1182\/blood-2016-08-692566"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Zhang E, Xu H. A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. J Hematol Oncol. 2017; 10: 1.","DOI":"10.1186\/s13045-016-0379-6"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Yang QX, Pei XJ, Tian XY, Li Y, Li Z. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature. Diagn Pathol. 2012; 7: 7.","DOI":"10.1186\/1746-1596-7-7"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Hu P, Ben Y, Liu J <i>et al.<\/i> Promising response to lenalidomide-combination therapy in a discordant lymphoma consisting of EBV-positive diffuse large B-cell lymphoma and angioimmunoblastic T-cell lymphoma: A case report. OncoTargets Ther. 2021; 14: 2489-2495.","DOI":"10.2147\/OTT.S297539"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Zettl A, Lee SS, R\u00fcdiger T <i>et al.<\/i> Epstein-Barr virus-associated B-cell lymphoproliferative disorders in angloimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, unspecified. Am J Clin Pathol. 2002; 117: 368-379.","DOI":"10.1309\/6UTX-GVC0-12ND-JJEU"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Kanakry JA, Hegde AM, Durand CM <i>et al.<\/i> The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016; 127: 2007-2017.","DOI":"10.1182\/blood-2015-09-672030"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Kondo S, Tanimoto K, Yamada K <i>et al.<\/i> Mature T\/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate. Virchows Arch. 2013; 462: 399-407.","DOI":"10.1007\/s00428-013-1389-1"},{"key":"17","unstructured":"17 Hoshida Y, Xu JX, Fujita S <i>et al.<\/i> Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007; 34: 322-331."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Tajima S, Takanashi Y, Koda K, Fukayama M. Methotrexate\u2010associated lymphoproliferative disorder presenting as extranodal NK\/T\u2010cell lymphoma arising in the lungs. Pathol Int. 2015; 65: 661-665.","DOI":"10.1111\/pin.12346"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Horwitz S, O\u2019Connor OA, Pro B <i>et al.<\/i> Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial. Lancet. 2019; 393: 229-240.","DOI":"10.1016\/S0140-6736(18)32984-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Pileri SA, Tabanelli V, Fiori S <i>et al.<\/i> Peripheral T-Cell lymphoma, not otherwise specified: clinical manifestations, diagnosis, and future treatment. Cancers (Basel). 2021; 13: 4535.","DOI":"10.3390\/cancers13184535"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Ito Y, Kimura H, Maeda Y <i>et al.<\/i> Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK\/T-cell lymphoma, nasal type. Clin Cancer Res. 2012; 18: 4183-4190.","DOI":"10.1158\/1078-0432.CCR-12-1064"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 El Hussein S, Patel KP, Fang H <i>et al.<\/i> Genomic and immunophenotypic landscape of aggressive NK-cell leukemia. Am J Surg Pathol. 2020; 44: 1235-1243.","DOI":"10.1097\/PAS.0000000000001518"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Lima M. Extranodal NK\/T cell lymphoma and aggressive NK cell leukaemia: evidence for their origin on CD56+bright CD16\u2013\/+dim NK cells. Pathology. 2015; 47: 503-514.","DOI":"10.1097\/PAT.0000000000000275"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/1\/64_23049\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T05:45:12Z","timestamp":1711777512000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/1\/64_23049\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23049","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23049"}}